Microalgae as an efficient vehicle for the production and targeted delivery of therapeutic glycoproteins against sars-cov-2 variants

HIGHLIGHTS

• who: Jaber Dehghani and colleagues from the Universitu00e9 de Rouen Normandie, Laboratoire GlycoMEV UR, SFR Normandie Vu00e9gu00e9tal FED, Innovation Chimie Carnot, Rouen, France Department of Plant, Cell and Molecular Biology, Faculty of Natural Sciences, University of Tabriz have published the research: Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants, in the Journal: (JOURNAL)
• how: Data showed that SARS-CoV-2 could not use other coronavirus recepFurther data showed that SARS-CoV-2 could not use other coronavirus receptors such as tors such as the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.